ArticleTranslational psychiatry2026
Cell deformability of peripheral blood mononuclear cells is reduced in individuals with major depressive disorder.
Article in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Major depressive disorder (MDD) is a complex mental disorder with a pathophysiology that remains only partly understood and involves, among other factors, alterations in immune system function. One of the main risk factors for mental disorders, in particular trauma-spectrum disorders like depression and complex PTSD, is childhood maltreatment (CM). However, their impact on the biophysical properties of immune cells remains unexplored. This study investigated PBMC deformability in 26 individuals diagnosed with MDD and 28 healthy controls. CM was assessed using the Childhood Trauma Questionnaire (CTQ). A microfluidic deformability assay was employed to assess immune cell deformability, with cell viability controlled in PBMC samples before measurement using trypan blue staining.PBMCs from individuals with MDD exhibited significantly reduced deformability compared to those from healthy controls, indicating increased cellular stiffness. CM was not significantly associated with PBMC deformability, suggesting that the MDD phenotype itself, with its multiple potential etiological causes, plays a more crucial role in cell stiffness than any single risk factor. These findings suggest that immune cell stiffness is elevated in MDD when assessed in isolated PBMCs, contrasting with previous studies that reported increased deformability measured in whole blood.Based on our working hypothesis, we interpret our results as indicative of damage to intracellular structures, including the cytoskeleton and cell membrane, likely due to increased exposure to free radicals from chronic or excessive stress. This may compromise membrane integrity and alter fatty acid composition. Functionally, these findings could enhance the biophysical understanding of impaired wound healing and other immunological dysfunctions commonly observed in MDD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.